Access & Support

Dedicated support for you and your patients.

From start to finish, our dedicated case managers are here to make every step of treatment simpler and more productive.

The PearConnect™ Patient Service Center has everything your clinic needs to meet its goal of helping every patient on their journey to recovery. Our dedicated case managers support you and your patients to seamlessly fit into the current workflows of your practice. For providers and clinics, PearConnect can help:

Facilitate patient access to reSET-O® or reSET®, and answer questions about treatment
Determine payer coverage on behalf of your patients
Assist you or your staff with general questions around ICD-10 diagnosis codes and CPT codes

For patients and their caregivers, PearConnect can help:

Deliver personalized onboarding guidance, product education, therapy initiation and adherence, and technical support
Determine insurance and benefits coverage, and copay assistance eligibility (eligible patients pay no more than $15 out of pocket for each prescription)
Provide information and support for access to the PEAR Assistance Program

Contact Us.

Call: 1-833-697-3738
Fax: 1-877-256-1320
Hours: 8 AM-8 PM (ET) Mon-Fri
Email: PearConnect@peartherapeutics.com

pear assistance program

Expanding access.

The PEAR Assistance Program ensures eligible patients living with substance use disorder or opioid use disorder have access to FDA-authorized prescription digital therapeutics for addiction treatment. This program provides access to reSET-O and reSET, free of charge, to qualifying patients who are currently under the supervision of a licensed US healthcare provider on an outpatient basis. Please contact us at 1-833-697-3738 for more information.

how to prescribe

Flexible prescribing options.

We provide two convenient ways to enroll your patients remotely—both are simple and secure. Click an option below to get started.

OPTION 1:
Use Your Electronic Prescription Tool (eRX).

Use this option if you have an eRx tool and the ability to e-prescribe. If you don’t, please use Option 2.

Select “Envoy Health” as the pharmacy:
325 Atherton Rd, Flint, MI 48507 | NPI: 1922181650 | NCPDP #: 2368834.
Select “reSET” or “reSET-O” as the prescription.
Ensure all required fields are complete before submitting.

- Prescribing Physician
- Prescriber NPI #
- Sig/Directions
- Dispense Quantity (enter “1”)
- Route (enter “N/A” or “Other”)
- Diagnosis Code
- Patient Name, DOB & Phone Number
- In Notes Section:
  - Indicate Contingency Management (CM) (enter “CM Virtual Rewards” or “CM Monetary Rewards”)
  - Indicate whether patient is on buprenorphine (enter “Buprenorphine”)*
  - Include patient’s insurance information and home address, if available
    
    *If not included, a PearConnect representative will call your office to confirm this information.

Your patient will be contacted by the PearConnect Patient Service Center, who will obtain their consent via phone or email. Encourage your patient to enter the PearConnect number into their phone so the # isn’t blocked and missed.

OPTION 2:
Use the Remote Enrollment Form (editable PDF).

Use this option if you do not have an eRx tool, but want to write a remote prescription for your patient.

Complete an editable PDF Enrollment Form below. Be sure to include a phone number for a direct contact who can confirm daily prescriptions.
Email the completed Enrollment Form to PearConnect@PearTherapeutics.com.
The Pear Connect Patient Service Center will reach out to you or your office staff via phone once a day to confirm the prescriptions for your patients.

A patient signature is not required on the enrollment form. Your patient will be contacted by the Patient Service Center, who will obtain their consent via phone or email.

Download Remote Enrollment Form

Experience reSET-O or reSET.

reSET-O

Indications for Use:

reSET-O prescription digital therapeutic is a 12-week (84 day) software application intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

Important Safety Information for Clinicians:

Warnings: reSET-O is intended for patients whose primary language is English and who have access to an Android/iOS tablet or smartphone. reSET-O is intended only for patients who own a smartphone and are familiar with use of smartphone apps (applications).

Clinicians should not use reSET-O to communicate with their patients about emergency medical issues. Patients should be clearly instructed not to use reSET-O to communicate to their clinician any urgent or emergent information. In case of an emergency, patients should dial 911 or go to the nearest emergency room.

reSET-O is not intended to be used as a stand-alone therapy for Opioid Use Disorder (OUD). reSET-O does not replace care by a licensed medical practitioner. reSET-O does not represent a substitution for a patient’s medication. Patients should continue to take their medications as directed by their healthcare provider. The ability of reSET-O to prevent potential relapse after therapy discontinuation has not been studied.

The long-term benefit of reSET-O has not been evaluated in studies lasting beyond 12 weeks (84 days) in the OUD population. The ability of reSET-O to prevent potential relapse after therapy discontinuation has not been studied.

Please see the Clinician Brief Summary Instructions for reSET-O.

reSET

Indications for Use:

reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older, who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12-week (90 day) prescription-only treatment for patients with substance use disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse.

It is intended to:

increase abstinence from a patient’s substances of abuse during treatment, and
increase retention in the outpatient treatment program.

Important Safety Information for Clinicians:

Warnings: reSET is intended for patients whose primary language is English and who have access to an Android/iOS tablet or smartphone. reSET is intended only for patients who own a smartphone and are familiar with use of smartphone apps (applications).

Clinicians should not use reSET to communicate with their patients about emergency medical issues. Patients should be clearly instructed not to use reSET to communicate to their clinician any urgent or emergent information. In case of an emergency, patients should dial 911 or go to the nearest emergency room.

reSET is not intended to be used as a stand-alone therapy for substance use disorder (SUD). reSET does not replace care by a licensed medical practitioner. reSET does not represent a substitution for a patient’s medication. Patients should continue to take their medications as directed by their healthcare provider.

The long-term benefit of treatment with reSET on abstinence has not been evaluated in studies lasting beyond 12 weeks (90 days) in the SUD population. The ability of reSET to prevent potential relapse after treatment discontinuation has not been studied.

Please see the Clinician Brief Summary Instructions for reSET.